Home -> Law Blog Directory -> Patent Law Blogs -> I/P Updates
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: I/P Updates83% Chance of Patent Term Extension Due to USPTO Delay
By William F. Heinze
[As shown by the histogram], 72% of the issued patents include at least some 154(b) extended patent term. Among those with an extended term, the average extension is 392 days. Slightly over 10% of the issued patents were granted an extension of three months (0.25 years) or less. A cumulative frequency chart of this same data would show that just over 50% of all the issued patents have a term extension lasting more than six months.
. . . Of course, the extension term is correlated with the length of time in prosecution. This scatter plot shows that relationship quite well. . . .
. . . Primary examiners are ?quicker? ? i.e., that patents examined by a primary examiner issue more quickly and with fewer amendments than those examined by assistant examiners. . . . As may be guessed, issued patents associated with an ?assistant examiner? are much more likely to have an extension. (78% of patents with assistant examiner have extension compared with 69% of patents examined only by a primary examiner). It appears that at least some of the quickness is due to the examiner actually acting more quickly (rather than merely compromising more easily).
Similarly, continuations are much less likely to receive extensions than patents without any ancestral history. (78% of patents with no ancestry have extension
compared with only 61% of patents that reference one or more parent). That
result is explained by the PTO?s procedure of reviewing continuation applications on a priority basis. Combining these numbers, I find a recipe for delay: In this study a patent with no ancestry that is examined by an assistant examiner has an 83% chance of received extensions due to PTO delay.
Full post as published by I/P Updates on March 14, 2008 (boomark / email).
Gambling Governed by State Laws
State laws vary with respect to gambling
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Pesticides
Long-Term Exposure Linked to Diabetes
Long-Term Insurance Suit
Settled for $15 Million
UnumProvident
for allegedly denying long-term disability claims.

USPTO Rejects SYMBICORT Patent Extension
Synergy Wont Save Patent Term Extension For Combination of Known Drugs
Extending the Patent Term: Most Patents Are Extended Due to PTO Delay
Patently-O Bits and Bytes No. 53
$65,000,000 for a PTE Application Thats Living the High Life.
USPTO News: USPTO and UKIPO Extend Patent Prosecution Highway Pilot Program







